Cue Biopharma, Inc. (CUE) Stock Price

CUEStock

$26.76−6.46%52W

Market Cap$194.40M

P/E—

PEG Ratio—

Div yield—

Beta2.67

CUE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)148.91%

Price vs S&P 500 (4W)-26.42%

VGM Score65.95

Book Value / Share (Quarterly)$6.64

P/TBV (Annual)3.15x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)180.09%

Cash Flow / Share (Quarterly)$-7.56

Price vs S&P 500 (YTD)141.37%

Net Profit Margin (TTM)-59.65%

EPS (TTM)$-5.52

10-Day Avg Trading Volume0.23M

EPS Excl Extra (TTM)$-5.52

Revenue Growth (5Y)54.20%

EPS (Annual)$-8.43

ROI (Annual)-100.64%

Net Profit Margin (5Y Avg)-1199.06%

Cash / Share (Quarterly)$5.03

Revenue Growth QoQ (YoY)1250.59%

ROA (Last FY)-63.02%

Revenue Growth TTM (YoY)309.60%

EBITD / Share (TTM)$-5.16

ROE (5Y Avg)-123.60%

Operating Margin (TTM)-59.90%

Cash Flow / Share (Annual)$-6.79

P/B Ratio6.07x

P/B Ratio (Quarterly)1.04x

Net Income / Employee (Annual)$-917,300

EV / Revenue (TTM)3.51x

ROA (TTM)-53.69%

EPS Incl Extra (Annual)$-8.43

Current Ratio (Annual)2.74x

Quick Ratio (Quarterly)3.34x

3-Month Avg Trading Volume0.44M

52-Week Price Return-6.46%

Revenue / Employee (TTM)$1,128,700

Tangible BV / Share (Quarterly)$1.95

P/S Ratio (Annual)4.78x

Asset Turnover (Annual)0.65x

52-Week High$45.50

Operating Margin (5Y Avg)-1208.72%

EPS Excl Extra (Annual)$-8.43

CapEx CAGR (5Y)-21.66%

Tangible BV CAGR (5Y)1.35%

26-Week Price Return160.16%

Quick Ratio (Annual)2.64x

13-Week Price Return15.32%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.57x

Enterprise Value$114.88M

Revenue / Share Growth (5Y)139.76%

Asset Turnover (TTM)0.90x

Book Value / Share Growth (5Y)25.85%

Revenue / Employee (Annual)$947,100

Pretax Margin (Annual)-95.03%

Cash / Share (Annual)$8.43

3-Month Return Std Dev124.08%

Net Income / Employee (TTM)$-673,200

ROE (Last FY)-100.64%

EPS Basic Excl Extra (Annual)$-8.43

Receivables Turnover (TTM)12.23x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-5.52

Receivables Turnover (Annual)8.46x

ROI (TTM)-93.30%

P/S Ratio (TTM)4.01x

Pretax Margin (5Y Avg)-1198.04%

Revenue / Share (Annual)$8.70

Tangible BV / Share (Annual)$3.69

Price vs S&P 500 (52W)-24.77%

Year-to-Date Return153.33%

5-Day Price Return-9.81%

EPS Normalized (Annual)$-8.43

ROA (5Y Avg)-76.57%

Net Profit Margin (Annual)-96.85%

Month-to-Date Return-13.64%

Cash Flow / Share (TTM)$-1.17

EBITD / Share (Annual)$-8.30

Operating Margin (Annual)-96.67%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-107.31%

LT Debt / Equity (Quarterly)0.01x

EPS Basic Excl Extra (TTM)$-5.52

P/TBV (Quarterly)4.48x

P/B Ratio (Annual)1.05x

Pretax Margin (TTM)-58.12%

Book Value / Share (Annual)$8.21

Price vs S&P 500 (13W)12.53%

Beta2.67x

Revenue / Share (TTM)$6.81

ROE (TTM)-98.30%

52-Week Low$4.97

vGradeC

gGradeA

mGradeC

vgmGradeB

CUE Earnings Surprise History

Q2 25-2.70est. -3.90

Q3 25-2.10est. -2.55

Q4 250.30est. -2.70

Q1 26-1.08est. —

Q2 26-24.14est. -1.69

CUE Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
CUECue Biopharma, Inc.	C	A	C	$26.76
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Cue Biopharma, Inc.

Cue Biopharma is a clinical-stage biopharmaceutical company developing a proprietary class of biologics designed to selectively modulate the immune system for treating cancer and autoimmune diseases. The company's pipeline includes CUE-101 (alone and in combination with Pembrolizumab), CUE-102, CUE-103, and other candidates leveraging its immune modulation platform.